NCT05448625Completed
Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry)
Safety and Efficacy of Sirolimus-eluting Biodegradable Abluminal Coating Stents in Patients With a High Risk of Ischemic Events: a Single-center, Prospective, Observational Trial (GENTLE Registry)
Source: ClinicalTrials.gov · Last updated 25 Nov 2025
Brief summary (registry, in English)
This is a prospective cohort study to evaluate the long-term effect and safety of Genoss drug-eluting stents (DES) in patients with coronary artery disease with high ischemic features.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 21 Jun 2022
- Start date
- 26 May 2022
- Primary completion date
- 14 May 2025
- Lead sponsor
- Yonsei University
- Diseases
- Coronary artery disease
- NCT number
- NCT05448625
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 26 May 2022 to the primary completion date, 14 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for PCI, cobalt chromium, Sirolimus or contrast media
Other
- Subject did not sign informed consent for data release
- Pregnancy
- Subject with life expectancy less than 12 months
- Subject with cardiogenic shock
Who the study is looking for
- Subject is ≥ 19 years
- Subject has signed informed consent for data release
Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yongin Severance Hospital Coordinator of this site? Confirm its status | Yŏngin | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.